SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-015116
Filing Date
2023-05-18
Accepted
2023-05-18 16:19:37
Documents
13
Period of Report
2023-05-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230518_8k.htm   iXBRL 8-K 22365
  Complete submission text file 0001437749-23-015116.txt   170551

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230515.xsd EX-101.SCH 4077
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230515_def.xml EX-101.DEF 13569
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230515_lab.xml EX-101.LAB 17786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230515_pre.xml EX-101.PRE 13536
7 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230518_8k_htm.xml XML 4414
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 23936360
SIC: 2836 Biological Products, (No Diagnostic Substances)